AI assistant
El.En. — Investor Presentation 2017
Sep 29, 2017
4393_cp_2017-09-29_46c6055a-2d7a-4db7-a658-81830a10d736.pdf
Investor Presentation
Open in viewerOpens in your device viewer
COMPANY PRESENTATION
We Laser your World
ITALIAN CONFERENCE 2017, JPMORGAN Sept. 29th , 2017
DISCLAIMER
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.
AGENDA
The El.En. Group
The El.En. Group
A Primary Player Providing Medical, Industrial, and Conservation Laser Solutions Worldwide
Hi-Tech company
International Group
Hi-Tech industrial group active in opto-electronics with proprietary technologies and knowhow developed over 35 years
More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment
Among the leaders in the global market
Worldwide distribution network
Progressively widening its worldwide presence registered continuous growth over the years
1,100 employees worldwide, more than 40,000 laser sources sold
Constant Growth
13% Revenue CAGR 2011 – 2016
40% EBIT CAGR 2011 – 2016
FY 2016 Consolidated Revenue at €253m, up 16% YoY, H1 2017 €143m up 19%
5
El.En. Worldwide
OurStrenghts
- Dynamic R&D activity performed in several centers of excellence
- Exploiting 35 years of know how
- Competition through incremental and breakthrough innovations
- Worldwide presence through a wide network of distributors with direct distribution in selected countries
- Multi brand approach to maximize penetration in medical markets
Our Markets
Medical& Aesth energy-based systems market
| \$ l l U S i i m o n |
2 0 1 4 |
2 0 1 6 |
2 0 2 1 |
C A G R |
C A G R |
|
|---|---|---|---|---|---|---|
| 6 1 4- 1 |
6- 2 1 1 |
|||||
| l b l l l i i d i i G o a n o n- n a s e a n m n m a v v y |
||||||
| d l h i i i i t t t t t n v a s v e m e c a a e s e c r e a m e n |
||||||
| t s y s e m s |
6. 9 3 2 |
8. 4 3 7 |
1 3. 9 9 2 |
1 0 % |
1 1 % |
|
| b d E t t t t n e r g y a s e r e a m e n s y s e m s - |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
1 5 % |
1 0 % |
|
| d h & k h B i S i i i t t o y s a p n g n g e n n g |
7 2 4 |
9 9 6 |
1. 9 6 5 |
1 7 % |
1 5 % |
|
| k S i j i t n r e u v e n a o n |
5 2 3 |
6 9 5 |
1. 0 8 9 |
1 5 % |
9 % |
|
| l H i a r r e m o v a |
3 5 3 |
3 4 1 |
3 3 3 |
-2 % |
0 % |
|
| L i t t t e g v e n r e a m e n s |
1 3 1 |
1 5 7 |
1 8 7 |
9 % |
4 % |
|
| d i A t c n e r e c o n u |
9 6 |
1 1 0 |
1 2 5 |
% 7 |
% 3 |
|
| l i j i V t a n a r e e n a o n g u v |
n a |
1 0 5 |
3 3 2 |
n a |
% 2 6 |
|
| d l & l P i i t t t t g m e n e e s o n a o o r e m o v a |
8 0 |
9 9 |
1 4 2 |
% 1 1 |
% 7 |
|
| h O t e r |
1 2 6 |
1 6 7 |
2 0 7 |
1 5 % |
4 % |
|
| l T t o a |
2. 0 3 3 |
2. 6 7 0 |
4. 3 8 0 |
1 5 % |
1 0 % |
Source: Medical Insight Report
Key growth drivers:
- Increasingly aging population
- Desire to achieve or maintain more youthful appearance
- Increase in healthcare spending
- Requirements for fast and minimally invasive surgical procedures
Industrial laser market
Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity
- •Sheet metal cutting: technology breakthroughs lead to strong widening of demand
- •Laser marking for identification: traceability as a quality standard
Market forecast for high power laser systems: 2016-2020 CAGR 7,6%
Source: Optech Consulting
Growth drivers
Growthdrivers
- Expected growth in our main markets: Aesthetic , Surgery, Industrial
- Novel body contouring and cellulite treatment device
- Novel dermatologic treatment device
- Picosecond tattoo removal lasers: new wavelength and max peak power
- Broaden indications of use for MonaLisa Touch through extensive clinicals
- Diabetic foot ulcers: seeking regulatory clearances worldwide
- >1 kW RF CO2laser source launched @ Laser 2017
- Strong demand for high power laser sheet metal cutting systems in China and Europe
A pathof growth
- Constant growth driven by strong execution and favorable market conditions
- 2016 EBITDA margin 12,8% and EBIT margin 10,9%
Financial Highlights
Financials2016
| & l L i i i P M F D t a n n a n a a a c - |
/ / 3 1 1 2 1 5 |
% | / / 3 1 1 2 1 6 |
% | V % a r. |
|---|---|---|---|---|---|
| R e v e n u e s |
2 1 7 6 7 0 |
% 1 0 0 0 , |
2 5 2 6 4 6 |
% 1 0 0 0 , |
% 1 6 1 , |
| E B I T D A |
2 6 6 6 5 |
8 % 1 1, |
3 2 3 8 8 |
2, 8 % 1 |
2 6 2 % , |
| E B I T |
2 1 4 9 9 |
9 9 % , |
2 7 5 9 4 |
1 0 9 % , |
2 8 4 % , |
| N I t e n c o m e |
1 4 3 7 1 |
% 6 6 , |
4 0 4 0 8 |
% 1 6, 0 |
% 1 8 1, 2 |
| R e v e n u e s |
/ / 3 1 1 2 1 5 |
% | / / 3 1 1 2 1 6 |
% | % V a r. |
| d l i M e c a |
1 1 0 2 4 7 |
6 6 % 7 , |
1 6 6 0 6 5 |
6 % 5, 7 |
1 2, 9 % |
| l d I i t n u s r a |
7 0 5 6 8 |
3 2, 4 % |
8 6 5 9 0 |
3 4 3 % , |
2 2, 7 % |
IncomeStatement H1-2017
| l l E M i i u r o o n |
/ / 3 0 0 6 2 0 1 6 |
% | / / 3 0 0 6 2 0 1 7 |
% | % V a r. |
|---|---|---|---|---|---|
| R | 1 2 0 1 7 6 |
1 0 0 0 % |
1 4 2 8 7 7 |
1 0 0 0 % |
1 8 9 % |
| e e n e s v u G i r o s s m a r g n |
3 2 6 4 5 |
, 4 4 3 % , |
9 0 9 5 5 |
, 4 1, % 7 |
, 1 1, % 7 |
| E B I T D A |
6 1 5 5 7 |
3 0 % 1 , |
6 9 1 5 4 |
0 8 % 1 , |
0 6 % - , |
| E B I T |
3 2 1 5 4 |
3 % 1 1, |
3 3 1 1 4 |
9 2 % , |
2, 9 % - |
| P I t r e a x n c o m e |
3 5 9 7 9 |
% 2 9 9 , |
1 0 8 8 1 |
% 7 6 , |
% 6 9 8 - , |
| i N t e n c o m e |
3 0 2 9 3 |
% 2 5 2 , |
6 0 1 0 |
% 4 2 , |
% 8 0 2 - , |
| h I N t e n c o m e p e r s a r e |
1, 5 7 |
0 3 1 , |
Balance SheetH1-2017
| l l E M i i u r o o n |
/ / 3 1 1 2 2 0 1 6 |
/ / 3 0 0 6 2 0 1 7 |
V % a r. |
|---|---|---|---|
| l T t t t o a n o n c u r r e n a s s e s |
6 4 7 3 7 |
6 4 5 6 2 |
% 0 3 - |
| k l i C i N W t t e o r n g a p a |
6 0 5 4 1 |
6 9 6 3 1 |
, 2 8 6 % , |
| f l i i i i N t t e n a n c a p o s o n |
8 2 8 4 7 |
6 6 9 4 7 |
1 9 3 % - , |
| l b l L i i i i t t o n g e r m a e s |
8 9 8 2 |
8 8 5 6 |
1, 4 % - |
| N E i t t e q u y |
1 9 2 6 9 9 |
1 9 2 1 3 1 |
% 0 3 - , |
| l l d i N t t e c a p a e m p o y e |
0 9 9 1 1 5 |
2 3 3 1 5 7 |
0 % 1 4 , |
| k l l i C i N W t t e o r n g a p a o n s a e s |
2 % 1 |
2 % 4 |
|
| O C R E |
2 % 5 |
2 1 % |
|
| / ( ) l l d I i E B T N t t e c a p a e m p o y e |
|||
| C a p e x |
1 1 4 4 1 |
1 6 3 6 |
H1 - Revenue breakdown
in Euro million
2017 Guidance
Multiples & Comparables
Multiples
| k h l d 's i h S E t t o c o e r q p e r s a r e u y |
9 | |
|---|---|---|
| / i k l d j. P B V A r c e o o a u e |
2, 6 |
|
| / ( ) 8 0 % E V E B I T E B I T |
8, 1 5 |
|
| / l ( l ) S 8 0 % S E V a e s a e s |
1, 7 |
|
| l. k E E M C t n. a r e a p. |
6 8, 0 @ 4 |
2 2 € 4, 5 |
| f l N i i i i t t e n a n c a p o s o n |
6 6, 8 @ |
/ / 3 0 0 6 2 0 1 7 |
| / i i l i l F t t t n a n a n e s m e n s m e r m c v |
1 2, 0 @ |
/ / 3 0 0 6 2 0 1 7 |
Comparables
| / d l he ica Ae ic Me t t s |
Pr ice |
Re ve nu e |
% Va r. Re ve nu e |
E B I T |
E B I T % |
M K. Ca p. |
E V |
/ les E V Sa ( *) |
/ E V E B I ( *) T |
h Ca s / d A j. P E ( *) |
/ k P Bo o lue Va |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cu te ra |
\$ 3 9, 6 5 |
\$ 6 6 8 8 5. |
3 2 % |
\$ 3 1 7 |
0 % |
\$ 3 0 0 5 5 5. |
\$ 0 2. 0 6 5 1 |
3, 8 |
9 9 7 1, |
2 7 1, 4 |
9, 2 |
| io las B e |
\$ 0, 6 0 |
\$ 2 3. 8 6 4 |
% -5 |
\$ ( ) 8. 6 5 5 |
-3 6 % |
\$ 9 0 4 5. 5 |
\$ 3 2 3 7. 4 |
0, 8 |
n.a | n.a | 8 1, |
| du ia l In tr s ho ics I P G P Co to n |
\$ 1 8 2, 0 8 |
\$ 6 5 5. 2 1 9 |
% 4 2 |
\$ 2 4 2. 6 2 3 |
% 3 7 |
\$ 9. 8 0 8. 0 0 0 |
\$ 8. 8 7 8. 7 7 3 |
6, 8 |
1 8, 3 |
2 4, 8 |
5, 4 |
| im du ie Pr In tr a s |
€ 3 9, 3 5 |
€ 2 0 2. 4 1 5 |
% 1 0 |
€ 1 0. 6 4 4 |
% 5 |
€ 4 1 2. 5 2 0 |
€ 5 0 8. 0 1 0 |
1, 3 |
2 3, 9 |
3 3, 8 |
3, 0 |
| l. ( ) E En 1 |
€ 2 4, 2 5 |
€ 1 4 2. 8 7 7 |
1 9 % |
€ 1 3. 1 3 4 |
9 % |
€ 4 6 7. 9 6 4 |
€ 3 8 9. 2 1 6 |
1, 7 |
1 8, 5 |
3 2, 4 |
2, 6 |
| ( ) d m l ip l ies 1 E V a t n u ( *) b d e Re E i t a ve nu e, n |
for iou as p rev s s ing ar n s a nn ua |
l i de l d ize |
Contacts
El.En. SPA
Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected]@polytemshir.it ; [email protected] Tel. +39 06-69923324